EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib

Lignende værker

• The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib
  af: Buder, Anna, et al.
  Udgivet: (2020)
• EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR
  af: Buder, Anna, et al.
  Udgivet: (2019)
• Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients
  af: Buder, Anna, et al.
  Udgivet: (2021)
• Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib
  af: Hochmair, Maximilian J., et al.
  Udgivet: (2018)
• Treating EGFR mutation resistance in non-small cell lung cancer – role of osimertinib
  af: Mazza, Valentina, et al.
  Udgivet: (2017)